Investigation of Naphthyl-Polyamine Conjugates as Antimicrobials and Antibiotic Enhancers.

Melissa M Cadelis, Liam R Edmeades, Dan Chen, Evangelene S Gill, Kyle Fraser, Florent Rouvier, Marie-Lise Bourguet-Kondracki, Jean Michel Brunel, Brent R Copp
Author Information
  1. Melissa M Cadelis: School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. ORCID
  2. Liam R Edmeades: School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  3. Dan Chen: School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  4. Evangelene S Gill: School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  5. Kyle Fraser: School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
  6. Florent Rouvier: Membranes et Cibles Thérapeutiques (MCT), SSA, INSERM, Aix-Marseille Universite, 27 bd Jean Moulin, 13385 Marseille, France.
  7. Marie-Lise Bourguet-Kondracki: Laboratoire Molécules de Communication et Adaptation des Micro-organismes, UMR 7245 CNRS, Muséum National d'Histoire Naturelle, 57 rue Cuvier (C.P. 54), 75005 Paris, France.
  8. Jean Michel Brunel: Membranes et Cibles Thérapeutiques (MCT), SSA, INSERM, Aix-Marseille Universite, 27 bd Jean Moulin, 13385 Marseille, France. ORCID
  9. Brent R Copp: School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. ORCID

Abstract

As part of our search for new antimicrobials and antibiotic enhancers, a series of naphthyl- and biphenyl-substituted polyamine conjugates have been synthesized. The structurally-diverse library of compounds incorporated variation in the capping end groups and in the length of the polyamine (PA) core. Longer chain (PA-3-12-3) variants containing both 1-naphthyl and 2-naphthyl capping groups exhibited more pronounced intrinsic antimicrobial properties against methicillin-resistant (MRSA) (MIC ≤ 0.29 µM) and the fungus (MIC ≤ 0.29 µM). Closer mechanistic study of one of these analogues, , identified it as a bactericide. In contrast to previously reported diarylacyl-substituted polyamines, several examples in the current set were able to enhance the antibiotic action of doxycycline and/or erythromycin towards the Gram-negative bacteria and . Two analogues ( and ) were of note, exhibiting greater than 32-fold enhancement in activity. This latter result suggests that α,ω-disubstituted polyamines bearing 1-naphthyl- and 2-naphthyl-capping groups are worthy of further investigation and optimization as non-toxic antibiotic enhancers.

Keywords

References

  1. J Med Chem. 2011 Aug 25;54(16):5786-95 [PMID: 21732630]
  2. Int J Mol Sci. 2023 Mar 20;24(6): [PMID: 36982955]
  3. Eur J Med Chem. 2023 Mar 5;249:115147 [PMID: 36739750]
  4. Microb Pathog. 2020 Sep;146:104238 [PMID: 32387392]
  5. Antibiotics (Basel). 2022 Apr 01;11(4): [PMID: 35453226]
  6. Eur J Med Chem. 2017 Nov 10;140:595-603 [PMID: 28988153]
  7. Chem Soc Rev. 2021 Jul 5;50(13):7820-7880 [PMID: 34042120]
  8. J Med Chem. 2017 Oct 26;60(20):8456-8465 [PMID: 28984451]
  9. Biol Direct. 2009 Jan 13;4:1 [PMID: 19144117]
  10. Biopolymers. 2008 May;89(5):360-71 [PMID: 18186149]
  11. J Chem Inf Model. 2015 Feb 23;55(2):460-73 [PMID: 25558886]
  12. Future Med Chem. 2016 Jun;8(9):963-73 [PMID: 27227839]
  13. Int J Mol Sci. 2023 Mar 12;24(6): [PMID: 36982501]
  14. ChemMedChem. 2015 Oct;10(10):1606-24 [PMID: 26386345]
  15. J Org Chem. 2001 Apr 6;66(7):2480-3 [PMID: 11281791]
  16. J Med Chem. 1964 Nov;7:710-6 [PMID: 14262793]
  17. Molecules. 2022 Jul 18;27(14): [PMID: 35889455]
  18. Int J Antimicrob Agents. 2004 Jul;24(1):67-71 [PMID: 15225864]
  19. Biomater Adv. 2023 Feb;145:213238 [PMID: 36527962]
  20. J Antimicrob Chemother. 2010 Aug;65(8):1688-93 [PMID: 20551217]
  21. Adv Drug Deliv Rev. 2021 Mar;170:261-280 [PMID: 33400958]
  22. Front Microbiol. 2021 Feb 22;12:616979 [PMID: 33692766]
  23. J Med Chem. 2019 Oct 10;62(19):8665-8681 [PMID: 31063379]
  24. J Med Chem. 2014 May 22;57(10):4263-72 [PMID: 24801877]
  25. ACS Infect Dis. 2015 Jul 10;1(7):285-7 [PMID: 27622818]
  26. Nat Rev Drug Discov. 2020 May;19(5):311-332 [PMID: 32107480]
  27. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1354-8 [PMID: 8433993]
  28. Eur J Med Chem. 2022 Nov 5;241:114632 [PMID: 36027613]
  29. Org Biomol Chem. 2014 Jun 21;12(23):3847-65 [PMID: 24668192]
  30. Antibiotics (Basel). 2020 Jan 13;9(1): [PMID: 31941022]
  31. Soft Matter. 2021 Mar 28;17(12):3404-3416 [PMID: 33645619]
  32. J Med Chem. 2001 Oct 11;44(21):3440-52 [PMID: 11585449]
  33. ACS Appl Mater Interfaces. 2020 May 13;12(19):21292-21299 [PMID: 31944092]
  34. RSC Adv. 2022 Sep 15;12(40):26220-26232 [PMID: 36275090]
  35. J Nat Prod. 2012 May 25;75(5):1001-5 [PMID: 22515429]
  36. Nat Rev Microbiol. 2021 Dec;19(12):786-797 [PMID: 34183822]

Grants

  1. 19-UOA-057-DDU/Catalyst: Seeding Dumont d'Urville NZ-France Science & Technology Support Programme
  2. 3718919/Maurice and Phyllis Paykel Trust

Word Cloud

Created with Highcharts 10.0.0antibioticpolyaminegroupsenhancersconjugatescappingantimicrobialMIC029µManaloguespolyaminesenhancementpartsearchnewantimicrobialsseriesnaphthyl-biphenyl-substitutedsynthesizedstructurally-diverselibrarycompoundsincorporatedvariationendlengthPAcoreLongerchainPA-3-12-3variantscontaining1-naphthyl2-naphthylexhibitedpronouncedintrinsicpropertiesmethicillin-resistantMRSAfungusClosermechanisticstudyoneidentifiedbactericidecontrastpreviouslyreporteddiarylacyl-substitutedseveralexamplescurrentsetableenhanceactiondoxycyclineand/orerythromycintowardsGram-negativebacteriaTwonoteexhibitinggreater32-foldactivitylatterresultsuggestsαω-disubstitutedbearing1-naphthyl-2-naphthyl-cappingworthyinvestigationoptimizationnon-toxicInvestigationNaphthyl-PolyamineConjugatesAntimicrobialsAntibioticEnhancersactivities

Similar Articles

Cited By (1)